TransDigm Group (TDG)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-07
$1329.40-1.24%
Close 2026-07-07 · 1-day change
Reading TDG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TDG free→NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-07
Reading TDG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TDG free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on growth through acquisitions and share buybacks. The current thesis state remains intact, supported by recent strong financial performance.
The market currently prices TDG at a premium compared to peers, indicating that investors expect continued strong performance. However, the valuation is considered expensive, suggesting that some caution is warranted given the mixed execution quality.
Fundamentals are likely to remain strong in the near term, supported by management's focus on revenue growth and share buybacks. However, there is a moderate risk due to the potential for missed earnings, especially given the recent history of misses in the industry.
The thesis hinges on the performance of sector bellwethers like SPCX, GE, and RTX. If these companies continue to perform well, TDG could benefit from positive sector momentum. Conversely, any negative guidance from these peers could impact TDG's outlook significantly.
In summary, TDG's long-term thesis is supported by solid recent results but is tempered by execution risks and sector dependencies. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. This improvement is driven by the latest earnings beat, which indicates strong financial performance. There are no current threats impacting the thesis.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Earnings results will show the company's financial health and growth path.
Confirms one read:Q2 earnings show revenue growth exceeding 10% year over year.
Confirms the other:Q2 earnings report shows revenue growth below 0% year over year.
Why it matters: Organic sales growth is key to long-term success. A drop below 9% signals weakness.
Confirms:Q3 organic sales growth reported below 9% year over year.
Disproves:Q3 organic sales growth reported at 9% or higher year over year.
Why it matters: A strong EBITDA margin shows good cost management and profit.
Confirms:EBITDA margin is above 52% for Q3.
Disproves:EBITDA margin is below 52% for Q3.
Why it matters: Completing this acquisition would help TransDigm grow. It would also strengthen its market position.
Confirms:The Stellant Systems acquisition is now complete.
Disproves:There could be delays or a cancellation of the Stellant Systems acquisition.
Why it matters: Updates on the buyback program show management's trust in the company's value.
Confirms one read:News of more share buybacks beyond the planned $905 million.
Confirms the other:No further share repurchases announced, or a halt in the buyback program.
Why it matters: More buybacks show strong capital use and a promise to return value to shareholders.
Confirms:Total share repurchases exceed $1 billion by the end of fiscal 2026.
Disproves:Share repurchases fall below $800 million for fiscal 2026.
Why it matters: If revenue guidance goes up, it shows the company expects stronger growth.
Confirms:Management raises revenue guidance for fiscal 2026 by more than 5%.
Disproves:Management keeps or lowers revenue guidance for fiscal 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.